Getein Biotech Inc banner

Getein Biotech Inc
SSE:603387

Watchlist Manager
Getein Biotech Inc Logo
Getein Biotech Inc
SSE:603387
Watchlist
Price: 9.4 CNY -2.69% Market Closed
Market Cap: ¥4.8B

Getein Biotech Inc
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Getein Biotech Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Getein Biotech Inc
SSE:603387
Non-Reccuring Items
¥2.8m
CAGR 3-Years
45%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Non-Reccuring Items
¥35.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Non-Reccuring Items
-¥569k
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
Non-Reccuring Items
-¥771.6k
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Getein Biotech Inc
Glance View

Market Cap
4.8B CNY
Industry
Biotechnology

Getein Biotech, Inc. engages in the business of medical health industry chain. The company is headquartered in Nanjing, Jiangsu and currently employs 2,125 full-time employees. The company went IPO on 2017-07-17. Its in vitro diagnostic reagents include Point-of-care Testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, hemagglutination reagents and others. Its diagnostic instruments include immunoquantitative analyzer FIA 8000, immunoquantitative analyzer FIA 8600, fluorescence immunoquantitative analyzer Getein 1100, fluorescence immunoquantitative analyzer Getein 1180, automatic biochemical analyzer CM 400, automatic chemiluminescence analyzer MAGICL 6000 and five classification blood cell analyzer BHA-5000, among others. The firm also provides testing and agency services. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
7.07 CNY
Overvaluation 25%
Intrinsic Value
Price ¥9.4

See Also

What is Getein Biotech Inc's Non-Reccuring Items?
Non-Reccuring Items
2.8m CNY

Based on the financial report for Sep 30, 2025, Getein Biotech Inc's Non-Reccuring Items amounts to 2.8m CNY.

What is Getein Biotech Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
13%

The average annual Non-Reccuring Items growth rates for Getein Biotech Inc have been 45% over the past three years , 13% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett